Items where authors include "Stewart, G.D."

Article

Nathan, A., Gao, C., Light, A. et al. (22 more authors) (2024) Early oncological outcomes of delayed radical prostatectomy: A prospective, international, follow‐up analysis of the COVIDSurg‐Cancer study. BJUI Compass, 5 (12). pp. 1314-1323. ISSN 2688-4526

Alexander, C.E., Nathan, A., Light, A. et al. (22 more authors) (2024) Understanding the long‐term impact of the COVID‐19 pandemic on non‐muscle‐invasive bladder cancer outcomes: 12‐Month follow‐up data from the international, prospective COVIDSurg Cancer study. BJUI Compass, 5 (11). pp. 1158-1165. ISSN 2688-4526

Conroy, S. orcid.org/0000-0001-7167-4908, Catto, J.W.F. orcid.org/0000-0003-2787-8828, Bex, A. et al. (11 more authors) (2023) Diagnosis, treatment, and survival from kidney cancer: real-world National Health Service England data between 2013 and 2019. BJU International, 132 (5). pp. 541-553. ISSN 1464-4096

Adisa, A., Bahrami-Hessari, M., Bhangu, A. orcid.org/0000-0001-5999-4618 et al. (2460 more authors) (2023) Reducing the environmental impact of surgery on a global scale: systematic review and co-prioritization with healthcare workers in 132 countries. British Journal of Surgery, 110 (7). pp. 804-817. ISSN 0007-1323

Picciochi, M. orcid.org/0000-0003-0397-5076, Glasbey, J.C., Li, E. et al. (259 more authors) (2023) Elective surgical services need to start planning for summer pressures. British Journal of Surgery, 110 (4). pp. 508-510. ISSN 0007-1323

Glasbey, J.C., Abbott, T.E.F., Ademuyiwa, A. et al. (4500 more authors) (2022) Elective surgery system strengthening: development, measurement, and validation of the surgical preparedness index across 1632 hospitals in 119 countries. The Lancet, 400 (10363). pp. 1607-1617. ISSN 0140-6736

Dennison, R.A., Boscott, R.A., Thomas, R. et al. (9 more authors) (2022) A community jury study exploring the public acceptability of using risk stratification to determine eligibility for cancer screening. Health Expectations, 25 (4). pp. 1789-1806. ISSN 1369-6513

Eisen, T., Frangou, E., Oza, B. et al. (22 more authors) (2020) Adjuvant Sorafenib for Renal Cell Carcinoma at Intermediate or High Risk of Relapse: Results From the SORCE Randomized Phase III Intergroup Trial. Journal of Clinical Oncology, 38 (34). pp. 4064-4075. ISSN 0732-183X

Rossi, S.H., Fielding, A., Blick, C. et al. (3 more authors) (2019) Setting research priorities in partnership with patients to provide patient-centred urological cancer care. European Urology, 75 (6). pp. 891-893. ISSN 0302-2838